vs
INVO Fertility, Inc.(IVF)与AIRWA INC.(YYAI)财务数据对比。点击上方公司名可切换其他公司
AIRWA INC.的季度营收约是INVO Fertility, Inc.的1.7倍($3.0M vs $1.8M),AIRWA INC.净利率更高(-7.4% vs -150.5%,领先143.1%),AIRWA INC.同比增速更快(729.8% vs 22.6%),过去两年AIRWA INC.的营收复合增速更高(14.3% vs 12.8%)
INVO Fertility是一家专注于辅助生殖医疗解决方案的企业,核心产品为专利INVOcell阴道内培养装置,服务北美、欧洲等地区的生殖诊所与患者,致力于降低生育治疗门槛,为有需求的群体提供可负担的生殖医疗服务。
Flying W航空公司(FWA)起源于1961年,创始人在新泽西开设了Flying W机场,打造可通航降落的度假胜地,在20世纪60年代末70年代初曾是知名度较高的上市企业。该公司押注阿拉斯加石油开发,1969年发展至巅峰,吸引了马特拉克家族投资,还吸纳两名好莱坞演员加入董事会,并收购了阿拉斯加的Red Dodge航空,购入飞机借阿拉斯加输油管道项目谋求发展。
IVF vs YYAI — 直观对比
营收规模更大
YYAI
是对方的1.7倍
$1.8M
营收增速更快
YYAI
高出707.2%
22.6%
净利率更高
YYAI
高出143.1%
-150.5%
两年增速更快
YYAI
近两年复合增速
12.8%
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $1.8M | $3.0M |
| 净利润 | $-2.6M | $-221.8K |
| 毛利率 | — | 75.2% |
| 营业利润率 | -93.1% | 1.8% |
| 净利率 | -150.5% | -7.4% |
| 营收同比 | 22.6% | 729.8% |
| 净利润同比 | -62.2% | 83.8% |
| 每股收益(稀释后) | $-0.77 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IVF
YYAI
| Q4 25 | — | $3.0M | ||
| Q3 25 | $1.8M | $3.0M | ||
| Q2 25 | $1.9M | $3.0M | ||
| Q1 25 | $1.6M | $3.3M | ||
| Q4 24 | $1.7M | $3.3M | ||
| Q3 24 | $1.4M | $3.3M | ||
| Q2 24 | $1.8M | $-701.1K | ||
| Q1 24 | $1.6M | — |
净利润
IVF
YYAI
| Q4 25 | — | $-221.8K | ||
| Q3 25 | $-2.6M | $1.3M | ||
| Q2 25 | $-5.3M | $552.2K | ||
| Q1 25 | $-17.4M | $-411.2K | ||
| Q4 24 | $-3.6M | $-1.4M | ||
| Q3 24 | $-1.6M | $-4.2M | ||
| Q2 24 | $-2.2M | — | ||
| Q1 24 | $-1.6M | — |
毛利率
IVF
YYAI
| Q4 25 | — | 75.2% | ||
| Q3 25 | — | 75.2% | ||
| Q2 25 | — | 75.2% | ||
| Q1 25 | 35.2% | 77.3% | ||
| Q4 24 | 41.4% | 77.3% | ||
| Q3 24 | 31.0% | 77.3% | ||
| Q2 24 | 53.1% | — | ||
| Q1 24 | 45.3% | — |
营业利润率
IVF
YYAI
| Q4 25 | — | 1.8% | ||
| Q3 25 | -93.1% | 49.7% | ||
| Q2 25 | -160.4% | 42.7% | ||
| Q1 25 | -1042.1% | 16.2% | ||
| Q4 24 | -202.0% | 71.2% | ||
| Q3 24 | -90.7% | 74.6% | ||
| Q2 24 | -100.9% | — | ||
| Q1 24 | -95.7% | — |
净利率
IVF
YYAI
| Q4 25 | — | -7.4% | ||
| Q3 25 | -150.5% | 42.0% | ||
| Q2 25 | -283.6% | 18.4% | ||
| Q1 25 | -1060.1% | -12.6% | ||
| Q4 24 | -211.3% | -41.7% | ||
| Q3 24 | -113.8% | -129.0% | ||
| Q2 24 | -122.2% | — | ||
| Q1 24 | -101.3% | — |
每股收益(稀释后)
IVF
YYAI
| Q4 25 | — | $-0.05 | ||
| Q3 25 | $-0.77 | — | ||
| Q2 25 | $-13.30 | — | ||
| Q1 25 | $-12.53 | $-1.41 | ||
| Q4 24 | $14.86 | $6.43 | ||
| Q3 24 | $-15.11 | $-1.91 | ||
| Q2 24 | $-22.39 | $-30.98 | ||
| Q1 24 | $-7.55 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $107.0M |
| 总债务越低越好 | $2.0M | — |
| 股东权益账面价值 | $5.8M | $165.4M |
| 总资产 | $18.8M | $172.1M |
| 负债/权益比越低杠杆越低 | 0.34× | — |
8季度趋势,按日历期对齐
现金及短期投资
IVF
YYAI
| Q4 25 | — | $107.0M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $1.4M | ||
| Q1 25 | — | $4.3M | ||
| Q4 24 | — | $18.1M | ||
| Q3 24 | — | $18.2M | ||
| Q2 24 | — | $1.8M | ||
| Q1 24 | — | — |
总债务
IVF
YYAI
| Q4 25 | — | — | ||
| Q3 25 | $2.0M | — | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $7.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
IVF
YYAI
| Q4 25 | — | $165.4M | ||
| Q3 25 | $5.8M | $26.2M | ||
| Q2 25 | $2.6M | $25.3M | ||
| Q1 25 | $3.3M | $26.1M | ||
| Q4 24 | $12.7M | $8.0M | ||
| Q3 24 | $-23.3K | $9.4M | ||
| Q2 24 | $1.4M | $9.6M | ||
| Q1 24 | $10.2K | — |
总资产
IVF
YYAI
| Q4 25 | — | $172.1M | ||
| Q3 25 | $18.8M | $34.7M | ||
| Q2 25 | $19.3M | $32.9M | ||
| Q1 25 | $31.7M | $30.7M | ||
| Q4 24 | $46.4M | $21.6M | ||
| Q3 24 | $17.0M | $23.2M | ||
| Q2 24 | $17.8M | $23.2M | ||
| Q1 24 | $17.3M | — |
负债/权益比
IVF
YYAI
| Q4 25 | — | — | ||
| Q3 25 | 0.34× | — | ||
| Q2 25 | 1.83× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-1.8M | $-30.8M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | — |
| 自由现金流率自由现金流/营收 | -101.6% | — |
| 资本支出强度资本支出/营收 | 0.5% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-7.8M | — |
8季度趋势,按日历期对齐
经营现金流
IVF
YYAI
| Q4 25 | — | $-30.8M | ||
| Q3 25 | $-1.8M | $-1.1M | ||
| Q2 25 | $-1.7M | $-423.7K | ||
| Q1 25 | $-3.5M | $-133.8K | ||
| Q4 24 | $-617.4K | $779.4K | ||
| Q3 24 | $-640.8K | $-601.3K | ||
| Q2 24 | $-1.5M | $-460.3K | ||
| Q1 24 | $-260.6K | — |
自由现金流
IVF
YYAI
| Q4 25 | — | — | ||
| Q3 25 | $-1.8M | — | ||
| Q2 25 | $-1.7M | — | ||
| Q1 25 | $-3.6M | — | ||
| Q4 24 | $-696.3K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-1.5M | — | ||
| Q1 24 | $-310.3K | — |
自由现金流率
IVF
YYAI
| Q4 25 | — | — | ||
| Q3 25 | -101.6% | — | ||
| Q2 25 | -92.6% | — | ||
| Q1 25 | -216.9% | — | ||
| Q4 24 | -40.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -82.3% | — | ||
| Q1 24 | -19.7% | — |
资本支出强度
IVF
YYAI
| Q4 25 | — | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 3.2% | — |
现金转化率
IVF
YYAI
| Q4 25 | — | — | ||
| Q3 25 | — | -0.86× | ||
| Q2 25 | — | -0.77× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图